Paradigm Asset Management Co. LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,300 shares of the medical research company’s stock after selling 200 shares […]